Indomethacin and Ibuprofen

PreclinicalSmall molecule

CChina Medical University Hospital

Indomethacin and Ibuprofen is one of 5 small molecule programs targeting Infants. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

InfantsTerminated

InfantsPreclinical

Terminated

Competition

Competitive Landscape

7 competitors in Infants

#DrugCompanyPhaseTrials

Aranesp

Amgen

Phase 2

2 2

Dopram

HHikma Pharmaceuticals LLC

Phase 3

1 3

Cysteine Hydrochloride

Novartis

Phase 1

1 4

Ivig

Argenx

Preclinical

1 5

Indomethacin and Ibuprofen

CChina Medical University Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Infants1 trial

New Management Strategy of PDA for VLBW Preterm Infants

Terminated·—·N/A·NCT00239512·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Indomethacin and Ibuprofen. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Indomethacin and Ibuprofen compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Indomethacin and Ibuprofen. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — China Medical University Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: CChina Medical University Hospital

Indomethacin and Ibuprofen

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Infants1 trial

References

Drug Info

Quick Facts

Related News